ADAR1 Capital Management »

Morphic Hldg shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Morphic Hldg (MORF) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Morphic Hldg

Tip: Access up to 7 years of quarterly data

All positions including Morphic Hldg held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Morphic Hldg by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $694k 20k 35.20

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Morphic Hldg

EcoR1 Capital
BlackRock
Vanguard Group
State Street Corporation
Goldman Sachs Group
Silverarc Capital Management
Two Sigma Advisers
MPM Oncology Impact Management
Fiduciary Trust Company
Candriam Luxembourg S.C.A.
Two Sigma Investments
Omega Fund Management
Morgan Stanley
Alliancebernstein
Nuveen Asset Management

View all funds holding Morphic Hldg